This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
important for decision making in dose reduction of S-1 in case of renal impairment
This page is a summary of: Pharmacokinetic study of the oral fluorouracil antitumor agent S‐1 in patients with impaired renal function, Cancer Science, April 2019, Wiley,
DOI: 10.1111/cas.14025.
You can read the full text:
The following have contributed to this page
Current Pharmaceutical Analysis
Spectrophotometric determination of pharmaceuticals and this gives basic information of spectrophotometry. Also this review gives easy way to understand the determination of pharmaceuticals. Now a ...
Drug Design Development and Therapy
At present, there are many clinical trials of quzartinib in the treatment of acute myeloid leukemia. We summarize the existing clinical trials, indicating that quizartinib is an effective drug for ...
Current Drug Targets
This review covers information on H3N2 cases in india which is a type of influenza virus having symptoms like flu, fever and fatigue. lead to various deaths in india.H3N2 from the family of Orthomy...
